Jiuqiang Bio: Wholly-owned subsidiary obtains medical device registration certificate.

Sina Finance News on March 31st, Jiuhang Bio announced on March 31st that its wholly-owned subsidiary, Fuzhou Mai Xin Biotechnology Development Co., Ltd., recently received the "Medical Device Registration Certificate" issued by the National Medical Products Administration. The approved products include HER2 antibody reagents, progesterone receptor antibody reagents, and CD20 antibody reagents, with a validity period until March 26, 2031. These products enrich the company's product line in the field of in vitro diagnostic immunochemistry, which is conducive to enhancing core competitiveness and will have a positive impact on the company's future operations.